Key facts
- This page summarizes Tanya Durkee Urbach's Form 4 filing for CytoDyn Inc. (CYDY).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Jan 2024, 21:04.
Tanya Durkee Urbach - 03 Jan 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)
- Reporting relationship
- Director
- Issuer ticker
- CYDY
- Reported as of
- 03 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2024, 21:04:20 UTC
- Prior SEC filing
- 08 Sep 2022
- Next SEC filing
- 30 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Antonio Migliarese, Attorney-in-Fact for Tanya Durkee Urbach
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tanya Durkee Urbach filed Form 4 for CytoDyn Inc. (CYDY) on 05 Jan 2024.
Change
- Previous filing in this sequence was filed on 08 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYDY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 162,113
- Date
- 03 Jan 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYDY
transaction
Derivative
Non-qualified stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +800,000
- Change %
- Price
- $0.000000
- Shares after
- 800,000
- Date
- 03 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 800,000
- Exercise price
- $0.2100
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.